3.4.21.46 3T3-F442A cell - 755129 3.4.21.46 3T3-L1 cell - 755129 3.4.21.46 A-549 cell - 708370 3.4.21.46 adipocyte - 755129 3.4.21.46 AGS cell low levels of vegf-D mRNA 697096 3.4.21.46 artery PDGF-D is widely expressed in most neointimas in arteries exhibiting the chronic arteriopathy of chronic allograft nephropathy and is only weakly expressed in a small proportion of sclerotic arteries. The neointimal cells expressing PDGF-D are alpha-smooth muscle actin-expressing cells, but not infiltrating macrophages or endothelial cells 698194 3.4.21.46 blood - 709321 3.4.21.46 blood low expression 753616 3.4.21.46 blood parasitized red blood cells, pRBC, infected by Plasmodium falciparum, rosetting serum dependent for the strains FCR3S1.2 and Malayan Camp 683539 3.4.21.46 blood plasma - 668074, 668289 3.4.21.46 brain moderate expression 753616 3.4.21.46 breast cancer cell line PDGF-D high-expressing breast cancer cell line SUM-149 is more invasive compared to low-expressing cell lines 707940 3.4.21.46 C3H10T1/2 cell - 755129 3.4.21.46 egg unfertilized 683526 3.4.21.46 embryo hatchling 683526 3.4.21.46 embryo transcript levels steadily increased from day 28 post-fertilization to hatch 683526 3.4.21.46 fibroblast - 752876 3.4.21.46 gastric cancer cell - 710586 3.4.21.46 gastric cell line - 697096 3.4.21.46 gill high mRNA expression determined by real-time RT-PCR 708533 3.4.21.46 gill moderate expression 753602, 753616 3.4.21.46 head kidney - 753616 3.4.21.46 heart - 683526, 753616 3.4.21.46 heart high mRNA expression determined by real-time RT-PCR 708533 3.4.21.46 heart moderate expression 753602 3.4.21.46 hepatocyte - -, 732521 3.4.21.46 hepatocyte normal hepatocytes synthesize factor D constitutively. The liver may be a major source of plasma factor D 651513 3.4.21.46 intestine - 683526 3.4.21.46 intestine low expression 753616 3.4.21.46 intestine moderate expression 753602 3.4.21.46 intestine moderate mRNA expression determined by real-time RT-PCR 708533 3.4.21.46 KATO-III cell low levels of vegf-D mRNA 697096 3.4.21.46 kidney - 683526 3.4.21.46 kidney highest expression in the kidney in healthy adults 753616 3.4.21.46 kidney moderate expression 753602 3.4.21.46 kidney moderate mRNA expression determined by real-time RT-PCR 708533 3.4.21.46 kidney PDGF-D is uniformly expressed in visceral epithelial cells and arteriolar wall in normal kidneys, kidneys with acute vascular rejection, and kidneys with chronic allograft nephropathy. In kidneys with acute vascular rejection, PDGF-D is expressed in arterial medial smooth muscle cells, some adventitial cells, and some neointimal cells that also have alpha-smooth muscle actin expression 698194 3.4.21.46 liver - -, 670498, 683526, 732521, 753616 3.4.21.46 liver high expression 753602 3.4.21.46 liver moderate mRNA expression determined by real-time RT-PCR 708533 3.4.21.46 MCF-7 cell low PDGF-D expressing breast cancer cell line is less invasive 707940 3.4.21.46 MDA-MB-231 cell PDGF-D expressing breast cancer cell lines are more invasive compared to non-expressing cell lines 707940 3.4.21.46 MDA-MB-468 cell low PDGF-D expressing breast cancer cell line is less invasive 707940 3.4.21.46 MKN-28 cell low levels of vegf-D mRNA 697096 3.4.21.46 MKN-45 cell 5- to 8fold higher amounts of vegf-D mRNA as the other gastric cell lines 697096 3.4.21.46 additional information epithelial ovarian carcinoma and tumoral lymphatic vessels, high expression of VEGF-D is closely associated with the FIGO stage, intratumoral lymphatic vessels, tumoral lymphatic invasion, and lymph node metastasis as well as a shorter overall survival 695580 3.4.21.46 additional information present in distal tubule and duct. Absent from proximal tubule and interstitium 698194 3.4.21.46 muscle marginal expression 753602 3.4.21.46 muscle moderate expression 753616 3.4.21.46 muscle moderate mRNA expression determined by real-time RT-PCR 708533 3.4.21.46 NCI-H460 cell - 708370 3.4.21.46 peritoneal dialysis fluid - 36592 3.4.21.46 peritoneal dialysis fluid of patients on chronic ambulatory peritoneal dialysis 36590 3.4.21.46 plasma - 36579, 36582, 36583, 36584, 669356 3.4.21.46 podocyte - 698194 3.4.21.46 serum - 670101, 708131 3.4.21.46 SK-MES-1 cell - 708370 3.4.21.46 skin - 752876 3.4.21.46 spleen moderate expression 753616 3.4.21.46 spleen moderate mRNA expression determined by real-time RT-PCR 708533 3.4.21.46 spleen predominant expression 753602 3.4.21.46 stomach moderate mRNA expression determined by real-time RT-PCR 708533 3.4.21.46 urine - 36592 3.4.21.46 urine of patients with chronic renal failure 36591